4.5 Article

Herpes Labialis: A New Possibility for Topical Treatment with Well-Elucidated Drugs

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 110, Issue 10, Pages 3450-3456

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2021.06.029

Keywords

Local anesthetics; HSV; Semi-solid; Epithelial (drug) delivery

Funding

  1. Sao Paulo Research Foundation (FAPESP) [2015/26138-4]
  2. Brazilian National Council for Scientific and Technological Development (CNPq) [406500/2016-9]

Ask authors/readers for more resources

This study developed formulations containing anesthetics for the treatment of mucocutaneous infections caused by Herpes simplex virus. The formulations were able to reduce pain, show antiviral properties, and were proven effective in in vivo tests.
Mucocutaneous infections caused by Herpes simplex virus (HSV-1 and HSV-2) are characterized by the appearance of vesicles that cause pain and embarrassment to the carrier. The standard treatment is based on the use of antivirals in gels or ointments, however, relapses are common. Local anesthetics decrease the pain caused by the lesion, in addition to showing antiviral properties. Semi-solid form facilitates application and its transformation into a thin film favors the maintenance of the formulation in place, with a more discreet final aspect. The objective of this study was to develop and evaluate formulations containing anesthetics for the treatment of cold sores. For this purpose, two semi-solid film-forming formulations were developed and evaluated, containing HPMC K100, lidocaine (LIDO) and prilocaine (PRILO) combined with adjuvants, in the presence (F1T) or not (F1) of the absorption promoter Transcutol (R). The mixture of PRILO and LIDO resulted in the formation of a eutectic mixture (EM), essential for penetration of drugs into the skin. The quantification of drugs was performed by HPLC (High Performance Liquid Chromatography), and Transcutol (R) did not influence the release of drugs from the formulation. The bioadhesiveness of the formulation was evaluate and the drugs did not impair the adhesive potential of the polymers used. The formulations were evaluated in vivo for skin irritation and did not show any negative sign on macroscopic examination. The in vivo efficacy test proved the anesthetics' ability to decrease the lesions caused by HSV-1. Thus, the proposed formulations proved to be good alternatives to the treatment of oral lesions caused by HSV-1. (C) 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available